SRN-001

N/A

Report date: 2026/02/13 20:01:31

NME

Base Information

Drug NameSRN-001

Drug Alias NameSRN-001

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionRNA interferenceAmphiregulin inhibitors

TargetsAmphiregulin

Therapy Area/IndicationsIdiopathic Pulmonary FibrosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseChronic Kidney Disease-Mineral and Bone Disorder

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustraliaSouth Korea

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniessiRNAgen Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniessiRNAgen Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsIdiopathic Pulmonary FibrosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseChronic Kidney Disease-Mineral and Bone Disorder

Inactive IndicationsN/A

Other Information

ATC CodeN/A